1Department of Infectious Diseases and Tropical Medicine, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
*Corresponding Author: Department of Infectious Diseases and Tropical Medicine, Kermanshah University of Medical Sciences, Kermanshah, IR Iran. Email:, vaziri15@yahoo.com. Email: vaziri15@yahoo.com
Archives of Clinical Infectious Diseases:Vol. 4, issue 1; 19-23
Published online:Jan 31, 2009
Article type:Research Article
How to Cite:Vaziri S, Mokhtari Azad T, Najafi F, Janbakhsh A, Sayyad B, et al. Surveying Immunogenicity and Safety of Influenza Vaccination in Health Care Workers and HIV-Infected Individuals. Arch Clin Infect Dis. 2009;4(1):. doi:
Abstract
Background:
Influenza is a world-wide public health concern. It is one of the most important viral causes of acute respiratory illness, affecting all age groups, recurring several times during a lifetime. We assessed the antibody titers after vaccination against influenza among HIV-infected patients and health care workers (HCWs).
Patients and methods:
During this before-after study, the antibody responses were assessed in 60 HCW and 60 HIVinfected patients vaccinated with split influenza vaccine (influvac 2005/2006 Solvays influenza vaccines for the influenza season 2005/2006 in the northern hemisphere).
Results:
Although all participants had protective antibody levels against A(H1N1), A(H3N2), and B components of trivalent influenza vaccine (before vaccination), HIV-infected patients showed seroconversion against A(H1N1), A(H3N2), and B components in 75%, 45%, and 28.3% of cases, respectively. The corresponding values were 70%, 33.3%, and 53.3% among HCWs, respectively. There were no repots of any vaccine adverse reaction.
Conclusion:
A comparable rise in antibody titers against influenza antigens without any adverse reaction supports the previous recommendations for influenza vaccination. Such programs can effectively decrease the probability of influenza infection in both HCWs and HIV-infected patients who are not seriously immune compromised.
Alshehri AA, Irekeola AA. Seroprevalence of Seasonal Influenza A and B and Their Association with ABO/Rh Blood Groups Among Nurses in Najran, Saudi Arabia. Jundishapur J Microbiol. 2025;18(8):e160582. doi: https://doi.org/10.5812/jjm-160582
Janbakhsh A, Vaziri S, Sayad B, Afsharian M, Rezaei M, et al. Immune Response to Standard Dose of Hepatitis B Vaccine in HIV Positive Clients of Kermanshah Behavioral Diseases Counseling Center. Hepat Mon. 2006;6(2):. doi:
Aminian O, Moaven Saidi M, Sadeghniiat Haghighi K, Izadi N. Coverage and Long-Term Immunogenicity of Hepatitis B Vaccine in Healthcare Workers. Arch Clin Infect Dis. 2016;11(4):e35758. doi: https://doi.org/10.5812/archcid.35758
Kohpeima Jahromi V, Raoofi R, Zahedi R, Mosleh F, Ebrahimizadeh F, et al. Health Belief Model in Hospitals: Determining the Effective Factors on Influenza Vaccination. Health Scope. 2021;10(2):e113759. doi: https://doi.org/10.5812/jhealthscope.113759
Dastani M, Dadashi A. Comparison of the prevalence of influenza in the field troops who have received influenza vaccine, with a group that have not vaccinated in the common flu seasons. Ann Mil Health Sci Res. 2012;10(4):e67595. doi: